News
In a scientific advice letter, the CHMP stated: “On 5/22/2025, the CHMP met and adopted the advice to be given to the applicant. CHMP agrees that, depending on the setting, a role for MRDnegCR ...
17d
InvestorsHub on MSNEli Lilly’s Alzheimer’s Drug Kisunla Receives Positive CHMP RecommendationEli Lilly (NYSE:LLY) announced that its Alzheimer’s medication Kisunla (donanemab) has secured a favorable opinion from the European Medicines Agency’s Committee for Medicinal Products for Human Use ...
Eli Lilly has cleared a major hurdle in its bid to win European approval for its Alzheimer's disease drug Kisunla.
Biogen said a key European regulatory committee has recommended approval of its Zurzuvae treatment for women with postpartum depression. Biogen on Friday said a green light would make Zurzuvae the ...
Gilead Sciences (NASDAQ:GILD) announced on Friday that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has issued a positive recommendation for lenacapavir ...
NEW YORK – The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has recommended regulators approve Servier's IDH1/2 inhibitor Voranigo (vorasidenib) as a treatment for ...
Media Release SYDNEY, AUSTRALIA, Aug. 01, 2023 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep” or “the Company”), a clinical-stage biotechnology company developing ...
Deciphera Pharmaceuticals, LLC, a biopharmaceutical company focused on discovering, developing, and commercializing important new medicines, and Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, ...
Pfizer, BioNTech Get CHMP Backing for Updated Covid-19 Vaccine Provided by Dow Jones Jul 25, 2025, 3:45:00 AM ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results